Tags

Type your tag names separated by a space and hit enter

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
Diabet Med. 2008 Jan; 25(1):51-7.DM

Abstract

AIMS

Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically manifest vascular disease is unknown. The objectives of this study were to examine the impact of Type 2 diabetes and microalbuminuria on future CVD events.

METHODS

Patients with clinically manifest vascular disease (coronary, cerebral and peripheral vascular disease) from the Second Manifestation of Arterial disease study were followed up for 4 years. Data obtained from 1996-2006 were analysed. At baseline, there were 804 patients with Type 2 diabetes mellitus (mean age 60 years) and 2983 patients without. Incident CVD (n = 458) was defined as hospital-verified myocardial infarction, stroke, vascular death and the composite of these vascular events.

RESULTS

Both Type 2 diabetes [hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.16, 1.75] and microalbuminuria (HR 1.86, 95% CI 1.49, 2.33) increased the risk of new cardiovascular events in univariate analyses. From multivariable models, presence of diabetes remained significantly and independently related to incident CVD (HR 1.42, 95% CI 1.11, 1.80). Presence of microalbuminuria also remained significantly independently related to incident CVD (HR 1.38, 95% CI 1.07, 1.77). In diabetes-stratified analyses, the effect of microalbuminuria on CVD risk was observed only in patients with diabetes. In microalbuminuria-stratified analyses, the significant and independent effect of diabetes on CVD risk was shown only in the non-microalbuminuric group.

CONCLUSIONS

In this high-risk population, both microalbuminuria and Type 2 diabetes are important and independent risk factors for future CVD.

Authors+Show Affiliations

Julius Centre for Health Sciences and Primary Care, Utrecht, The Netherlands. s.s.soedamah-muthu@umcutrecht.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18199132

Citation

Soedamah-Muthu, S S., et al. "The Impact of Type 2 Diabetes and Microalbuminuria On Future Cardiovascular Events in Patients With Clinically Manifest Vascular Disease From the Second Manifestations of ARTerial Disease (SMART) Study." Diabetic Medicine : a Journal of the British Diabetic Association, vol. 25, no. 1, 2008, pp. 51-7.
Soedamah-Muthu SS, Visseren FL, Algra A, et al. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Diabet Med. 2008;25(1):51-7.
Soedamah-Muthu, S. S., Visseren, F. L., Algra, A., & van der Graaf, Y. (2008). The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Diabetic Medicine : a Journal of the British Diabetic Association, 25(1), 51-7. https://doi.org/10.1111/j.1464-5491.2007.02345.x
Soedamah-Muthu SS, et al. The Impact of Type 2 Diabetes and Microalbuminuria On Future Cardiovascular Events in Patients With Clinically Manifest Vascular Disease From the Second Manifestations of ARTerial Disease (SMART) Study. Diabet Med. 2008;25(1):51-7. PubMed PMID: 18199132.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. AU - Soedamah-Muthu,S S, AU - Visseren,F L J, AU - Algra,A, AU - van der Graaf,Y, AU - ,, PY - 2008/1/18/pubmed PY - 2008/4/26/medline PY - 2008/1/18/entrez SP - 51 EP - 7 JF - Diabetic medicine : a journal of the British Diabetic Association JO - Diabet Med VL - 25 IS - 1 N2 - AIMS: Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically manifest vascular disease is unknown. The objectives of this study were to examine the impact of Type 2 diabetes and microalbuminuria on future CVD events. METHODS: Patients with clinically manifest vascular disease (coronary, cerebral and peripheral vascular disease) from the Second Manifestation of Arterial disease study were followed up for 4 years. Data obtained from 1996-2006 were analysed. At baseline, there were 804 patients with Type 2 diabetes mellitus (mean age 60 years) and 2983 patients without. Incident CVD (n = 458) was defined as hospital-verified myocardial infarction, stroke, vascular death and the composite of these vascular events. RESULTS: Both Type 2 diabetes [hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.16, 1.75] and microalbuminuria (HR 1.86, 95% CI 1.49, 2.33) increased the risk of new cardiovascular events in univariate analyses. From multivariable models, presence of diabetes remained significantly and independently related to incident CVD (HR 1.42, 95% CI 1.11, 1.80). Presence of microalbuminuria also remained significantly independently related to incident CVD (HR 1.38, 95% CI 1.07, 1.77). In diabetes-stratified analyses, the effect of microalbuminuria on CVD risk was observed only in patients with diabetes. In microalbuminuria-stratified analyses, the significant and independent effect of diabetes on CVD risk was shown only in the non-microalbuminuric group. CONCLUSIONS: In this high-risk population, both microalbuminuria and Type 2 diabetes are important and independent risk factors for future CVD. SN - 1464-5491 UR - https://www.unboundmedicine.com/medline/citation/18199132/The_impact_of_Type_2_diabetes_and_microalbuminuria_on_future_cardiovascular_events_in_patients_with_clinically_manifest_vascular_disease_from_the_Second_Manifestations_of_ARTerial_disease__SMART__study_ L2 - https://doi.org/10.1111/j.1464-5491.2007.02345.x DB - PRIME DP - Unbound Medicine ER -